Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

UPECBCG

Financiado

Cerrado

Cellular and molecular mechanisms of bladder immune responses to uropathogens an...

Cellular and molecular mechanisms of bladder immune responses to uropathogens and therapeutics The bladder is a unique mucosal barrier devoid of colonizing microbiota and organized lymphoid structures. This research project will examine bladder immunobiology, specifically as it relates to urinary tract infection (UTI) and b... ver más

31/01/2017

INSERM

100K€

Presupuesto del proyecto: 100K€

Líder del proyecto

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHER... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2017-01-31 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

INSERM

0.00€ | Lider

Proyectos interesantes

SAF2014-58895-JIN

Medical Technol...

Immunology

204K€ Cerrado

MUC2GO

Medical Technol...

Immunology

3M€ Cerrado

SAF2014-56642-JIN

Medical Technol...

Immunology

204K€ Cerrado

GUT TC PHENOTYPES

Medical Technol...

Immunology

231K€ Cerrado

SAF2009-11592

Medical Technol...

Immunology

394K€ Cerrado

HOMEOGUT

Medical Technol...

Immunology

2M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHER... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 100K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The bladder is a unique mucosal barrier devoid of colonizing microbiota and organized lymphoid structures. This research project will examine bladder immunobiology, specifically as it relates to urinary tract infection (UTI) and bladder cancer. Notably, UTI is second only to respiratory infection in prevalence, and bladder cancer is the fifth leading cause of cancer. While commonalities between UTI and bladder cancer may not be immediately apparent, the most effective treatment for transitional cell carcinoma is intravesical instillation of BCG, or the direct introduction of bacteria into the bladder lumen. We will investigate bladder immune responses following uropathogenic E. coli (UPEC) or BCG instillation, with the aim to identify how dendritic cells (DCs) and T cells behave following bacterial interactions with what is a unique mucosal surface in the body. Specifically, we will test the hypotheses that (i) bladder-resident macrophages acquire UPEC antigen in the bladder and sequester it from DCs, limiting antigen presentation, while lymph node-resident DCs capture disseminated BCG and efficiently present it; and (ii) DCs that do capture UPEC antigen lack the ability to cross-present antigen whereas BCG-antigen loaded DCs have a greater capacity to activate CD8+ T cells. These hypotheses are based on animal model and clinical observations and will help establish a scientific foundation for exploring strategies to enhance UPEC antigen-specific responses, taking lessons from BCG’s capacity to induce cross-priming. The goal of these studies is to understand the differential outcomes in adaptive immune responses to BCG or UPEC thereby defining strategies to enhance clearance of UPEC and improve the efficacy of BCG-mediated tumor immunity. My dual training as a microbiologist and immunologist will ensure that attention is given to both the bacterium and the host in defining the differential regulation governing the respective disease processes.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores